Legend Biotech Corporation American Depositary Shares
Symbol: LEGN (NASDAQ)
32.90
▼ (-0.03%) -0.009
Company Description:
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.
Key Stats
- Today's Open: $33.122
- Today's High: $33.365
- Today's Low: $32.655
- Today's Volume: 57
- Yesterday Close: $32.91
- Yesterday High: $33.07
- Yesterday Low: $32.0345
- Yesterday Volume: 963.43K
- Last Min Volume: 0
- Last Min High: $32.917
- Last Min Low: $32.901
- Last Min VWAP: $0
Company Profile
- Name: Legend Biotech Corporation American Depositary Shares
- Website: https://www.legendbiotech.com
- Listed Date: 2020-06-05
- Location: ,
- Market Status: Active
- CIK Number: 0001801198
- SIC Code:
- SIC description:
- Market Cap: $6.07B
- Round Lot: 100
- Outstanding Shares: 184.57M
- Asset Type: ADRC
RECENT FILINGS FOR LEGN
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-10-14 | 6-K | View |
| 2025-10-14 | 6-K | View |
| 2025-10-07 | 6-K | View |
| 2025-09-26 | 144 | View |
| 2025-09-24 | 144 | View |
| 2025-09-23 | 144 | View |
| 2025-09-23 | 144 | View |
| 2025-09-23 | 144 | View |
| 2025-08-18 | 6-K | View |
| 2025-08-11 | 6-K | View |
| 2025-08-06 | SCHEDULE 13G/A | View |
| 2025-07-23 | 144 | View |
| 2025-07-23 | 144 | View |
| 2025-07-16 | 6-K | View |
| 2025-06-30 | 6-K | View |
| 2025-06-26 | 144 | View |
| 2025-06-25 | 144 | View |
| 2025-06-24 | 144 | View |
| 2025-06-24 | 144 | View |
| 2025-06-12 | 6-K | View |